These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7198445)

  • 1. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
    Clough DP; Hatton R; Pettinger SJ
    Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
    Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
    Timmermans PB; Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The withdrawal of centrally acting antihypertensives in dogs.
    Clough DP; Keddie J; Pettinger SJ
    Arzneimittelforschung; 1981; 31(11):1878-80. PubMed ID: 7198468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.
    Sannajust F; Cerutti C; Koenig-Bérard E; Sassard J
    Br J Pharmacol; 1992 Mar; 105(3):542-8. PubMed ID: 1352719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT; Wendt RL
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive effect of guanfacine in rats].
    Nakagawa Y; Takeda K; Hashimoto T; Sakurai H; Mitomi A; Imai S; Hamamura M; Kumada M
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):295-312. PubMed ID: 6762984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of brain cholinergic system in the antihypertensive effect of clonidine in different models of rat hypertension.
    Squadrito F; Quattrone G; Buemi M; Frisina N; Caputi AP; Squadrito G
    J Hypertens Suppl; 1985 Dec; 3(4):S97-9. PubMed ID: 3868718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
    Yoshioka M; Togashi H; Abe M; Ikeda T; Matsumoto M; Saito H
    J Pharmacol Exp Ther; 1990 May; 253(2):427-31. PubMed ID: 1692588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.